IFP Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $646K | Buy |
1,230
+206
| +20% | +$108K | 0.02% | 734 |
|
|
2025
Q1 | $649K | Buy |
1,024
+656
| +178% | +$416K | 0.02% | 695 |
|
|
2024
Q4 | $262K | Buy |
368
+54
| +17% | +$38.5K | 0.01% | 1008 |
|
|
2024
Q3 | $329K | Sell |
314
-237
| -43% | -$248K | 0.01% | 861 |
|
|
2024
Q2 | $578K | Buy |
551
+46
| +9% | +$48.3K | 0.02% | 613 |
|
|
2024
Q1 | $486K | Buy |
505
+16
| +3% | +$15.4K | 0.02% | 619 |
|
|
2023
Q4 | $430K | Buy |
489
+47
| +11% | +$41.3K | 0.02% | 630 |
|
|
2023
Q3 | $364K | Buy |
442
+39
| +10% | +$32.1K | 0.02% | 706 |
|
|
2023
Q2 | $290K | Buy |
403
+44
| +12% | +$31.6K | 0.01% | 850 |
|
|
2023
Q1 | $110K | Sell |
359
-741
| -67% | -$227K | ﹤0.01% | 1209 |
|
|
2022
Q4 | $364K | Sell |
1,100
-443
| -29% | -$147K | 0.01% | 1041 |
|
|
2022
Q3 | $589K | Buy |
1,543
+64
| +4% | +$24.4K | 0.02% | 847 |
|
|
2022
Q2 | $561K | Hold |
1,479
| – | – | 0.02% | 796 |
|
|
2022
Q1 | $561K | Buy |
1,479
+1,028
| +228% | +$390K | 0.02% | 796 |
|
|
2021
Q4 | $285K | Sell |
451
-70
| -13% | -$44.2K | 0.01% | 790 |
|
|
2021
Q3 | $313K | Buy |
521
+16
| +3% | +$9.61K | 0.01% | 724 |
|
|
2021
Q2 | $283K | Buy |
505
+202
| +67% | +$113K | 0.01% | 746 |
|
|
2021
Q1 | $140K | Buy |
303
+32
| +12% | +$14.8K | ﹤0.01% | 1000 |
|
|
2020
Q4 | $126K | Buy |
271
+90
| +50% | +$41.8K | 0.01% | 1017 |
|
|
2020
Q3 | $101K | Buy |
181
+19
| +12% | +$10.6K | 0.01% | 992 |
|
|
2020
Q2 | $102K | Sell |
162
-15
| -8% | -$9.44K | 0.01% | 919 |
|
|
2020
Q1 | $80K | Buy |
+177
| New | +$80K | 0.01% | 927 |
|
|
2019
Q4 | – | Sell |
-2,208
| Closed | -$598K | – | 3450 |
|
|
2019
Q3 | $598K | Buy |
+2,208
| New | +$598K | 0.04% | 447 |
|
|
2019
Q1 | $10K | Sell |
25
-264
| -91% | -$106K | ﹤0.01% | 1610 |
|
|
2018
Q4 | $105K | Sell |
289
-29
| -9% | -$10.5K | 0.01% | 1157 |
|
|
2018
Q3 | $128K | Buy |
318
+10
| +3% | +$4.03K | 0.01% | 1329 |
|
|
2018
Q2 | $106K | Buy |
308
+57
| +23% | +$19.6K | ﹤0.01% | 1434 |
|
|
2018
Q1 | $94K | Hold |
251
| – | – | ﹤0.01% | 1421 |
|
|
2017
Q4 | $94K | Sell |
251
-140
| -36% | -$52.4K | ﹤0.01% | 1419 |
|
|
2017
Q3 | $175K | Buy |
391
+6
| +2% | +$2.69K | 0.01% | 1214 |
|
|
2017
Q2 | $189K | Buy |
385
+96
| +33% | +$47.1K | 0.01% | 1154 |
|
|
2017
Q1 | $112K | Sell |
289
-13
| -4% | -$5.04K | ﹤0.01% | 1420 |
|
|
2016
Q4 | $111K | Sell |
302
-58
| -16% | -$21.3K | 0.01% | 1390 |
|
|
2016
Q3 | $145K | Buy |
360
+32
| +10% | +$12.9K | 0.01% | 1153 |
|
|
2016
Q2 | $115K | Buy |
328
+303
| +1,212% | +$106K | 0.01% | 1249 |
|
|
2016
Q1 | $10K | Sell |
25
-558
| -96% | -$223K | ﹤0.01% | 1610 |
|
|
2015
Q4 | $316K | Buy |
+583
| New | +$316K | 0.02% | 637 |
|